Trial Outcomes & Findings for 2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients (NCT NCT02490631)

NCT ID: NCT02490631

Last Updated: 2021-01-06

Results Overview

Evaluation daily using the CDC guidelines, daily measurements and deidentified photos

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

158 participants

Primary outcome timeframe

post op day 30

Results posted on

2021-01-06

Participant Flow

One participant signed consent, was randomized to the chlorhexidine arm, but their surgery was cancelled, so they did not start the study. There is no data for this subject.

Participant milestones

Participant milestones
Measure
Standard of Care Pre-operative Cleansing
Standard of care pre-operative cleansing with soap and water the night before and morning of surgery
2% Chlorhexidine Gluconate
2% chlorhexidine gluconate cloths the night before and morning of surgery 2% chlorhexidine gluconate cloths: Cleansing twice pre-operatively jawline to toes with 2% chlorhexidine gluconate cloths
Overall Study
STARTED
79
78
Overall Study
COMPLETED
76
75
Overall Study
NOT COMPLETED
3
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard of Care Pre-operative Cleansing
n=76 Participants
Standard of care pre-operative cleansing with soap and water the night before and morning of surgery
2% Chlorhexidine Gluconate
n=75 Participants
2% chlorhexidine gluconate cloths the night before and morning of surgery 2% chlorhexidine gluconate cloths: Cleansing twice pre-operatively jawline to toes with 2% chlorhexidine gluconate cloths
Total
n=151 Participants
Total of all reporting groups
Age, Continuous
63 years
n=76 Participants
66 years
n=75 Participants
64 years
n=151 Participants
Sex: Female, Male
Female
40 Participants
n=76 Participants
34 Participants
n=75 Participants
74 Participants
n=151 Participants
Sex: Female, Male
Male
36 Participants
n=76 Participants
41 Participants
n=75 Participants
77 Participants
n=151 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
76 participants
n=76 Participants
75 participants
n=75 Participants
151 participants
n=151 Participants

PRIMARY outcome

Timeframe: post op day 30

Evaluation daily using the CDC guidelines, daily measurements and deidentified photos

Outcome measures

Outcome measures
Measure
Standard of Care Pre-operative Cleansing
n=76 Participants
Standard of care pre-operative cleansing with soap and water the night before and morning of surgery
2% Chlorhexidine Gluconate
n=75 Participants
2% chlorhexidine gluconate cloths the night before and morning of surgery 2% chlorhexidine gluconate cloths: Cleansing twice pre-operatively jawline to toes with 2% chlorhexidine gluconate cloths
Participants With Surgical Site Infection Development at 30 Days Post-operative
5 Participants
5 Participants

SECONDARY outcome

Timeframe: Day of Surgery, Day of Discharge, 30 days post-op

Skin swabs collected on Day of Surgery, Day of Discharge, 30 days post-op

Outcome measures

Outcome measures
Measure
Standard of Care Pre-operative Cleansing
n=76 Participants
Standard of care pre-operative cleansing with soap and water the night before and morning of surgery
2% Chlorhexidine Gluconate
n=75 Participants
2% chlorhexidine gluconate cloths the night before and morning of surgery 2% chlorhexidine gluconate cloths: Cleansing twice pre-operatively jawline to toes with 2% chlorhexidine gluconate cloths
Number of Participants With Positive or Abnormal Skin Cultures on Day of Surgery, Day of Discharge, 30 Days Post-op
day of surgery
41 Participants
7 Participants
Number of Participants With Positive or Abnormal Skin Cultures on Day of Surgery, Day of Discharge, 30 Days Post-op
day of discharge
21 Participants
9 Participants
Number of Participants With Positive or Abnormal Skin Cultures on Day of Surgery, Day of Discharge, 30 Days Post-op
30 days post-op
32 Participants
25 Participants

Adverse Events

Standard of Care Pre-operative Cleansing

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

2% Chlorhexidine Gluconate

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Elizabeth Card

Vanderbilt University Medical Center

Phone: 615-875-4611

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place